載入中
NYSEConsumer DefensiveHousehold & Personal Products
最新資料
US$17.83
+US$0.13 · +0.73%
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
前收盤價
US$17.83
+US$0.13 · +0.73%
盤前
US$17.83
US$0.00 · 0.00%
10月13日 上午5:16 ET
盤中時間採用ET。市場資料可能有所延遲。
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
日內區間
目前US$17.83
52週區間
目前US$17.83
盤中時間採用ET。市場資料可能有所延遲。
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
日內區間
目前US$17.83
52週區間
目前US$17.83
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 151.24億 USD | 154.55億 USD | 154.44億 USD | 149.5億 USD | 150.54億 USD |
| 銷貨成本 | 63.32億 USD | 64.96億 USD | 68.01億 USD | 66.65億 USD | 66.35億 USD |
| 毛利 | 87.92億 USD | 89.59億 USD | 86.43億 USD | 82.85億 USD | 84.19億 USD |
| 研究與開發 | 3.82億 USD | — | — | — | — |
| 銷售、一般及管理費用 | 60.88億 USD | 60.27億 USD | 61.41億 USD | 56.33億 USD | 54.84億 USD |
| 營業費用 | 60.88億 USD | 71.18億 USD | 61.31億 USD | 56.1億 USD | 54.99億 USD |
| 利息收入 | — | 5300萬 USD | 1.08億 USD | — | — |
| 利息支出 | 3.79億 USD | 4.31億 USD | 3.58億 USD | — | — |
| 折舊和攤銷 | 5.57億 USD | 6.22億 USD | 6.27億 USD | 6.44億 USD | 7.31億 USD |
| 營業利益 | 27.04億 USD | 18.41億 USD | 25.12億 USD | 26.75億 USD | 29.2億 USD |
| 淨利 | 14.7億 USD | 10.3億 USD | 16.64億 USD | 20.64億 USD | 20.78億 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T656.37億0.05%130.34兆 JPY0.09%¥122,950+0.08%
Vanguard Morningstar Total Stock Market ETFVTI11.52億0.05%2.3兆 USD0.03%US$381.57-0.10%
Vanguard S&P 500 ETFVOO9.63億0.05%1.8兆 USD0.03%US$715.13-0.06%
Vanguard Morningstar Mid-Cap ETFVO7.84億0.35%2264億 USD0.03%US$80.92-0.27%
iShares Core S&P 500 ETFIVV4.52億0.05%8964.4億 USD0.03%US$781.44-0.07%
State Street SPDR S&P 500 ETFSPY4.14億0.05%8216.79億 USD0.09%US$778.1-0.06%
Vanguard Morningstar Value ETFVTV3.46億0.13%2624億 USD0.03%US$221.43+0.38%
State Street SPDR S&P Dividend ETFSDY3.1億1.49%206.92億 USD0.35%US$150.38+0.90%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street SPDR S&P Dividend ETFSDYAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
